Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (421-430 of 611) with videos related to

Pageof 62
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimersAttila Szederjesi, Luciano Baronciani, Ulrich Budde, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 27, 2024
Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia BRichard Lemons, Michael Wang, Julie Curtin, et al.
Journal of Autoimmunity|January 16, 2021
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19Luca Valenti, Samantha Griffini, Giuseppe Lamorte, et al.
Blood|April 19, 2022
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study resultsFrank W G Leebeek, Flora Peyvandi, Miguel Escobar, et al.
Thrombosis and Haemostasis|May 12, 2010
Early-onset ischaemic stroke: analysis of 58 polymorphisms in 17 genes involved in methionine metabolismBetti Giusti, Claudia Saracini, Paola Bolli, et al.
Blood Advances|June 30, 2022
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpuraChristian Bichard, Ilaria Mancini, Pasquale Agosti, et al.
Journal of Autoimmunity|May 3, 2021
Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595]Luca Valenti, Samantha Griffini, Giuseppe Lamorte, et al.
Expert Review of Hematology|August 30, 2023
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label studyRobert F Sidonio, Alexis A Thompson, Flora Peyvandi, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery diseaseIlaria Guella, Valeria Rimoldi, Rosanna Asselta, et al.
Thrombosis Research|July 10, 2013
Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effectNatascha C J Mathijssen, Rosalinde Masereeuw, Pal Andre Holme, et al.
Pageof 62

Showing results (421-430 of 611) with videos related to

Sort By:
Pageof 62
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimersAttila Szederjesi, Luciano Baronciani, Ulrich Budde, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 27, 2024
Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia BRichard Lemons, Michael Wang, Julie Curtin, et al.
Journal of Autoimmunity|January 16, 2021
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19Luca Valenti, Samantha Griffini, Giuseppe Lamorte, et al.
Blood|April 19, 2022
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study resultsFrank W G Leebeek, Flora Peyvandi, Miguel Escobar, et al.
Thrombosis and Haemostasis|May 12, 2010
Early-onset ischaemic stroke: analysis of 58 polymorphisms in 17 genes involved in methionine metabolismBetti Giusti, Claudia Saracini, Paola Bolli, et al.
Blood Advances|June 30, 2022
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpuraChristian Bichard, Ilaria Mancini, Pasquale Agosti, et al.
Journal of Autoimmunity|May 3, 2021
Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595]Luca Valenti, Samantha Griffini, Giuseppe Lamorte, et al.
Expert Review of Hematology|August 30, 2023
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label studyRobert F Sidonio, Alexis A Thompson, Flora Peyvandi, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery diseaseIlaria Guella, Valeria Rimoldi, Rosanna Asselta, et al.
Thrombosis Research|July 10, 2013
Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effectNatascha C J Mathijssen, Rosalinde Masereeuw, Pal Andre Holme, et al.
Pageof 62